[Treatment with plasma concentrates in hemophilia A. State Security and Health Planning Office. Expert Panel].
D001769:Blood / Q000382:microbiology; D003894:Deamino Arginine Vasopressin / Q000627:therapeutic use; D005169:Factor VIII / Q000009:adverse effects / Q000302:isolation & purification / Q000592:standards / Q000627:therapeutic use*; D006467:Hemophilia A / Q000628:therapy*; D017325:Hepatitis B Vaccines; D006801:Humans; D007153:Immunologic Deficiency Syndromes / Q000209:etiology; D007518:Isoantibodies / Q000096:biosynthesis; D012449:Safety; D014777:Virus Diseases / Q000517:prevention & control / Q000635:transmission
D017325:Hepatitis B Vaccines; D007518:Isoantibodies; D005169:Factor VIII; D003894:Deamino Arginine Vasopressin
Tratamiento con concentrados plasmaticos en la hemofilia A. Dirección General de Aseguramiento y Planificación Sanitaria. Panel de Expertos]